Pershing Square [PSH] vs Tetragon Financial [TFG] Detailed Stock Comparison

Pershing Square
Euronext
Loading...

Tetragon Financial
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Pershing Square wins in 2 metrics, Tetragon Financial wins in 9 metrics, with 0 ties. Tetragon Financial appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Pershing Square | Tetragon Financial | Better |
---|---|---|---|
P/E Ratio (TTM) | 4.41 | 2.25 | Tetragon Financial |
Price-to-Book Ratio | N/A | 0.42 | N/A |
Debt-to-Equity Ratio | 0.00 | 9.87 | Pershing Square |
PEG Ratio | 13.47 | N/A | N/A |
Profit Margin (TTM) | N/A | 70.54% | N/A |
Operating Margin (TTM) | N/A | 72.43% | N/A |
EBITDA Margin (TTM) | N/A | 72.43% | N/A |
Return on Equity | 9.02% | 21.90% | Tetragon Financial |
Return on Assets (TTM) | 7.51% | 12.40% | Tetragon Financial |
Free Cash Flow (TTM) | $-1.27B | $47.10M | Tetragon Financial |
Dividend Yield | N/A | 3.49% | N/A |
1-Year Return | 13.66% | 81.17% | Tetragon Financial |
Price-to-Sales Ratio (TTM) | 7.81 | 1.51 | Tetragon Financial |
Enterprise Value | $0 | $1.84B | Tetragon Financial |
EV/Revenue Ratio | 0.00 | 1.86 | Pershing Square |
Revenue per Share (TTM) | $7 | $11 | Tetragon Financial |
Earnings per Share (Diluted) | $6.38 | $7.94 | Tetragon Financial |
Beta (Stock Volatility) | N/A | -0.09 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pershing Square vs Tetragon Financial Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Pershing Square | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.45% |
Tetragon Financial | 2.58% | 7.19% | 10.15% | 34.49% | 16.23% | 26.95% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Pershing Square | 13.66% | 56.13% | 105.17% | 89.36% | 125.23% | 125.23% |
Tetragon Financial | 81.17% | 73.79% | 99.33% | 69.67% | 321.18% | 81.73% |
Performance & Financial Health Analysis: Pershing Square vs Tetragon Financial
Metric | PSH | TFG |
---|---|---|
Market Information | ||
Market Cap | $9.41B | $1.49B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 3,388 | 15,343 |
90 Day Avg. Volume | 1,129 | 18,154 |
Last Close | $51.60 | $17.90 |
52 Week Range | $44.30 - $53.10 | $9.72 - $18.00 |
% from 52W High | -2.82% | -0.56% |
All-Time High | $55.90 (Jun 10, 2024) | $1,002.75 (Dec 22, 2014) |
% from All-Time High | -7.69% | -98.21% |
Growth Metrics | ||
Quarterly Revenue Growth | N/A | 6.45% |
Quarterly Earnings Growth | N/A | 10.69% |
Financial Health | ||
Profit Margin (TTM) | N/A | 0.71% |
Operating Margin (TTM) | N/A | 0.72% |
Return on Equity (TTM) | 0.09% | 0.22% |
Debt to Equity (MRQ) | 0.00 | 9.87 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | N/A | $42.59 |
Cash per Share (MRQ) | N/A | $0.04 |
Operating Cash Flow (TTM) | $-779,377,787 | $10.60M |
Levered Free Cash Flow (TTM) | $1.17B | $622.80M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 3.49% |
Last 12-Month Dividend | N/A | $0.55 |
Valuation & Enterprise Metrics Analysis: Pershing Square vs Tetragon Financial
Metric | PSH | TFG |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 4.41 | 2.25 |
Forward P/E | 13.47 | N/A |
PEG Ratio | 13.47 | N/A |
Price to Sales (TTM) | 7.81 | 1.51 |
Price to Book (MRQ) | N/A | 0.42 |
Market Capitalization | ||
Market Capitalization | $9.41B | $1.49B |
Enterprise Value | $0 | $1.84B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.00 | 1.86 |
Enterprise to EBITDA | N/A | N/A |
Risk & Other Metrics | ||
Beta | N/A | -0.09 |
Book Value per Share (MRQ) | N/A | $42.59 |
Financial Statements Comparison: Pershing Square vs Tetragon Financial
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | PSH | TFG |
---|---|---|
Revenue/Sales | N/A | N/A |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | N/A |
EBITDA | N/A | N/A |
Pre-Tax Income | N/A | N/A |
Income Tax | N/A | N/A |
Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | PSH | TFG |
---|---|---|
Cash & Equivalents | $436.52M | $30.50M |
Total Current Assets | N/A | N/A |
Total Current Liabilities | N/A | N/A |
Long-Term Debt | $2.32B | $300.00M |
Total Shareholders Equity | $13.01B | $3.17B |
Retained Earnings | $8.12B | $2.34B |
Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | PSH | TFG |
---|---|---|
Operating Cash Flow | N/A | $35.80M |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | $83.40M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | $-57.10M |
Short Interest & Institutional Ownership Analysis
Metric | PSH | TFG |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 3,388 | 15,343 |
Average Daily Volume (90 Day) | 1,129 | 18,154 |
Shares Outstanding | 182.96M | 87.30M |
Float Shares | N/A | N/A |
% Held by Insiders | N/A | 0.18% |
% Held by Institutions | N/A | 0.01% |
Dividend Analysis & Yield Comparison: Pershing Square vs Tetragon Financial
Metric | PSH | TFG |
---|---|---|
Last 12-Month Dividend | N/A | $0.55 |
Last 12-Month Dividend Yield | N/A | 3.49% |
3-Year Avg Annual Dividend | N/A | $0.48 |
3-Year Avg Dividend Yield | N/A | 1.01% |
3-Year Total Dividends | N/A | $1.43 |
Ex-Dividend Date | N/A | Jun 05, 2025 |